Recent PRFX News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/16/2024 08:35:07 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/16/2024 08:30:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/10/2024 09:25:08 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/04/2024 04:15:05 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/30/2024 08:15:14 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 09/20/2024 08:30:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/11/2024 01:36:40 PM
- PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110 • GlobeNewswire Inc. • 09/11/2024 12:30:00 PM
- PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds • GlobeNewswire Inc. • 09/10/2024 01:46:37 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/10/2024 01:13:25 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/04/2024 08:16:00 PM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 08/28/2024 08:30:23 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 08/27/2024 09:07:43 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/26/2024 09:00:07 PM
- PainReform Bunionectomy Study Observations Confirm Optimal Delivery Method for PRF-110 in Bunionectomy Procedures • GlobeNewswire Inc. • 08/21/2024 12:30:00 PM
- PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study • GlobeNewswire Inc. • 08/20/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/15/2024 08:45:16 PM
- PainReform Provides Business Update for the Second Quarter of 2024 • GlobeNewswire Inc. • 08/15/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/13/2024 08:30:08 PM
- PainReform Announces Development and Successful Manufacturing of New Formulations Providing Anti-Inflammatory and Extended Analgesic Effects • GlobeNewswire Inc. • 08/12/2024 01:00:00 PM
- PainReform Announces Favorable Safety Profile of PRF-110, Indicating Potential for Use in New Surgical Applications Requiring Higher Doses • GlobeNewswire Inc. • 08/07/2024 02:00:00 PM
- PainReform Ltd. Announces Favorable Wound Healing Data in Human Clinical Trials for PRF-110 • GlobeNewswire Inc. • 08/05/2024 01:00:00 PM
- PainReform’s New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room Temperature • GlobeNewswire Inc. • 08/01/2024 12:30:00 PM
- PainReform Files Patent Covering Highly Scalable Manufacturing Process for PRF-110 Following Successful Completion and Testing • GlobeNewswire Inc. • 07/24/2024 12:30:00 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM